1211 related articles for article (PubMed ID: 31165961)
41. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
Saha S; Mara K; Pardi DS; Khanna S
Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
[TBL] [Abstract][Full Text] [Related]
42. Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis.
Agarwal A; Maheshwari A; Verma S; Arrup D; Phillips L; Vinayek R; Nair P; Hagan M; Dutta S
Dig Dis Sci; 2021 Jun; 66(6):2000-2004. PubMed ID: 32656604
[TBL] [Abstract][Full Text] [Related]
43. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.
Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989
[TBL] [Abstract][Full Text] [Related]
44. Faecal microbiota transplantation in patients with
Lahtinen P; Mattila E; Anttila VJ; Tillonen J; Teittinen M; Nevalainen P; Salminen S; Satokari R; Arkkila P
World J Gastroenterol; 2017 Oct; 23(39):7174-7184. PubMed ID: 29093626
[TBL] [Abstract][Full Text] [Related]
45. The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection.
Jalanka J; Hillamaa A; Satokari R; Mattila E; Anttila VJ; Arkkila P
Aliment Pharmacol Ther; 2018 Feb; 47(3):371-379. PubMed ID: 29226561
[TBL] [Abstract][Full Text] [Related]
46. Fecal Microbiota Transplantation for Refractory and Recurrent
Bang BW; Park JS; Kim HK; Shin YW; Kwon KS; Kwon HY; Baek JH; Lee JS
Korean J Gastroenterol; 2017 Apr; 69(4):226-231. PubMed ID: 28449424
[TBL] [Abstract][Full Text] [Related]
47. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
[TBL] [Abstract][Full Text] [Related]
48. [Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders].
Li N; Tian H; Ma C; Ding C; Ge X; Gu L; Zhang X; Yang B; Hua Y; Zhu Y; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):40-46. PubMed ID: 28105618
[TBL] [Abstract][Full Text] [Related]
49. Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
Juszczuk K; Grudlewska K; Mikucka A; Gospodarek E
Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):220-226. PubMed ID: 28345530
[TBL] [Abstract][Full Text] [Related]
50. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
[TBL] [Abstract][Full Text] [Related]
51. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
[TBL] [Abstract][Full Text] [Related]
52. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
Cohen NA; Livovsky DM; Yaakobovitch S; Ben Yehoyada M; Ben Ami R; Adler A; Guzner-Gur H; Goldin E; Santo ME; Halpern Z; Paz K; Maharshak N
Isr Med Assoc J; 2016 Oct; 18(10):594-599. PubMed ID: 28471618
[TBL] [Abstract][Full Text] [Related]
53. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent
Peri R; Aguilar RC; Tüffers K; Erhardt A; Link A; Ehlermann P; Angeli W; Frank T; Storr M; Glück T; Sturm A; Rosien U; Tacke F; Bachmann O; Solbach P; Stallmach A; Goeser F; Vehreschild MJ;
United European Gastroenterol J; 2019 Jun; 7(5):716-722. PubMed ID: 31210950
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
[TBL] [Abstract][Full Text] [Related]
55. Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study.
Baunwall SMD; Hansen MM; Andreasen SE; Eriksen MK; Rågård N; Kelsen J; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
Aliment Pharmacol Ther; 2023 Sep; 58(5):503-515. PubMed ID: 37482926
[TBL] [Abstract][Full Text] [Related]
56. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.
Kelly CR; Ihunnah C; Fischer M; Khoruts A; Surawicz C; Afzali A; Aroniadis O; Barto A; Borody T; Giovanelli A; Gordon S; Gluck M; Hohmann EL; Kao D; Kao JY; McQuillen DP; Mellow M; Rank KM; Rao K; Ray A; Schwartz MA; Singh N; Stollman N; Suskind DL; Vindigni SM; Youngster I; Brandt L
Am J Gastroenterol; 2014 Jul; 109(7):1065-71. PubMed ID: 24890442
[TBL] [Abstract][Full Text] [Related]
57. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D
Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484
[TBL] [Abstract][Full Text] [Related]
58. [Effect of intestinal preparation on the efficacy and safety of fecal microbiota transplantation treatment].
Chen QY; Tian HL; Yang B; Lin ZL; Zhao D; Ye C; Zhang XY; Qin HL; Li N
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(Z1):48-55. PubMed ID: 32594726
[No Abstract] [Full Text] [Related]
59. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
[TBL] [Abstract][Full Text] [Related]
60. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
Song Y; Garg S; Girotra M; Maddox C; von Rosenvinge EC; Dutta A; Dutta S; Fricke WF
PLoS One; 2013; 8(11):e81330. PubMed ID: 24303043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
